0001898714-22-000001.txt : 20221129 0001898714-22-000001.hdr.sgml : 20221129 20221129093553 ACCESSION NUMBER: 0001898714-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221129 DATE AS OF CHANGE: 20221129 EFFECTIVENESS DATE: 20221129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bonum Therapeutics, Inc. CENTRAL INDEX KEY: 0001898714 IRS NUMBER: 872883314 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-465970 FILM NUMBER: 221428857 BUSINESS ADDRESS: STREET 1: 1616 EASTLAKE AVENUE EAST CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-888-8485 MAIL ADDRESS: STREET 1: 1616 EASTLAKE AVENUE EAST CITY: SEATTLE STATE: WA ZIP: 98102 D 1 primary_doc.xml X0708 D LIVE 0001898714 Bonum Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 SEATTLE WA WASHINGTON 98102 206-888-8485 DELAWARE None None Corporation true 2021 John Mulligan c/o Bonum Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Executive Officer Director Promoter John McKearn c/o Bonum Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Director Monique Schiersing c/o Bonum Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Director Nicholas Walrod c/o Bonum Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Director Karl Handelsman c/o Bonum Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Director Diane Hollenbaugh c/o Bonum Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Executive Officer Neela Patel c/o Bonum Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Executive Officer Mitchell Mutz c/o Bonum Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Director Samuel Bjork c/o Bonum Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Director Biotechnology Decline to Disclose 06b false 2022-11-15 false true false 0 93041420 45041421 47999999 false 10 0 0 0 false Bonum Therapeutics, Inc. /s/ John Mulligan John Mulligan Chief Executive Officer 2022-11-29